CADEM:通过CRISPR检测真菌cfDNA的物种级检测,用于肺部疾病诊断
Seungil Park1, Bonhan Koo1, Myoung Gyu Kim1
1Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
Analytica chimica acta
|January 29, 2026
概括
一个新的诊断系统,CADEM,准确地识别出 Mycobacterium tuberculosis (MTB) 和非结核菌 (NTM),如液体活检中的 MAC 和 MABC. 这种基于CRISPR的快速测试为诊断肺部感染提供了比传统方法更快,更敏感的替代方案.
科学领域:
- 分子诊断学 分子诊断学
- 微生物学 微生物学
- 生物技术是生物技术.
背景情况:
- 由Mycobacterium tuberculosis (MTB) 和非结核菌 (NTM) 引起的肺部感染由于类似的症状和不同的治疗方法,造成了诊断上的挑战.
- 准确的物种识别NTM,如Mycobacterium avium复合体 (MAC) 和Mycobacterium复合体 (MABC),对于有效的治疗至关重要.
- 传统的诊断是缓慢的,现有的分子测试缺乏分辨率,通常需要唾液,突出需要改进的方法.
研究的目的:
- 开发一种快速,灵敏和准确的诊断系统,用于区分MTB,MAC和MABC.
- 利用液体活检和CRISPR/Cas12a技术进行细菌cfDNA的微创检测.
- 创建一个精简的工作流程,用于物种级别的真菌细菌肺病原体的鉴定.
主要方法:
- 开发CADEM (使用微流体技术通过丰富Mycobacterium衍生cfDNA进行CRISPR辅助检测).
- 微流体cfDNA丰富,有针对性的放大和CRISPR/Cas12a检测的整合.
- 利用优化的Cas12a-crRNA复合体进行敏感和特定的安普利康检测.
主要成果:
- 与传统的PCR方法相比,CADEM的灵敏度提高了10到100倍.
- 该系统准确地识别了20个临床标本中的所有MAC,MABC和MTB病例,没有假阳性.
- 在2小时的工作流程内获得了物种级结果,CRISPR检测在20分钟内提供了清晰的光读取.
结论:
- CADEM提供了一种准确和精简的分子诊断方法,用于分化MAC,MABC和MTB的物种水平.
- 该系统能够有效地分析液体活检样本,用于肺部疾病诊断.
- CADEM与异热放大器的兼容性支持在资源有限的环境中进行治疗点测试的潜在适应.
相关概念视频
01:59CRISPR
57.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.8K
01:24Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
02:53CRISPR and crRNAs
19.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:17What is a Species?
49.8K
Overview
49.8K